(0.01) - (0.02)
Net loss $(0.17) $(0.01) $(0.38) $(0.18)
Weighted average common
and common equivalent
shares outstanding
Basic 24,942 24,587 24,811 23,421
Diluted 24,942 24,587 24,811 23,421
Three Months Ended Year Ended
December 31, December 31,
2007 2006 2007 2006
STATEMENT OF CASH FLOW DATA:
Net cash provided by
(used in):
Operations $(2,096) $(61) $(4,943) $(3,110)
Investing (1,150) (96) (4,062) (10,609)
Financing 266 395 10,180 11,010
Discontinued Operations - 433 - (41)
December 31,
2007 2006
BALANCE SHEET DATA:
Cash and cash equivalents $7,132 $6,015
Total assets 27,691 27,544
Deferred revenue 3,664 4,401
Long-term debt (excluding
capital leases) 6,247 -
Stockholder's equity 12,862 16,196
'/>"/>SOURCE eDiets.com, Inc. Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 Related medicine news :1.
eDiets.com(R) Updates Timing of Third Quarter 2007 Earnings Conference Call2.
HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness3.
CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael4.
UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West5.
HEI, Inc. Announces Sale of RFID Division Assets6.
Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)7.
Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference8.
Z Trim Announces Revocation of Gregory Halpern Severence Agreement9.
Brooke Franchise Corporation Announces Selected July Results10.
Manor Care, Inc. Announces Record Date for Special Stockholder Meeting11.
Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)